Trade DCOY anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Decoy Therapeutics Inc. (DCOY) is trading at US$2.97, up 0.13% today as of Aug 28, 12:42 EDT. The company has a market capitalisation of US$2.1M. Over the past 52 weeks, DCOY has traded between US$0.51 and US$16.92. On Syfe you can trade DCOY with $0 commission and add it to your watchlist.
| Previous close | US$2.97 |
|---|---|
| Market cap | US$2.1M |
| 52-week range | US$0.51 – US$16.92 |
| Volume | 17.72K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Decoy Therapeutics Inc.
Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. It engages in leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company was founded by Frederick E. Pierce, Barbara Hibner, Peter Marschel, Michael Lipp, and Jodi Cooper in 2020 and is headquartered in Houston, TX.
Year: 2015
Decoy Therapeutics Files to Register Up to 3.77 Million Shares for Resale
Jul 10, 8:45 PM · MT Newswires
Top Premarket Decliners
Jun 30, 11:35 AM · MT Newswires
Top Midday Gainers
Jun 29, 5:36 PM · MT Newswires
Decoy Therapeutics Inc. (DCOY) stock is trading at US$2.97, +0.13% from the previous close of US$2.97.
The market cap for Decoy Therapeutics Inc. (DCOY) stock is approximately US$2.1M.
The 52-week high for Decoy Therapeutics Inc. (DCOY) stock is US$16.92.
The 52-week low for Decoy Therapeutics Inc. (DCOY) stock is US$0.51.
Decoy Therapeutics Inc. (DCOY) does not currently pay a dividend.
Stay on top of DCOY
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot